Author

David P. Carbone

Institution: The Ohio State University

Observed institutions: National Institutes of Health, Henry Ford Health, Vanderbilt University, Henry Ford Hospital, National Cancer Institute, National Cancer Center Hospital East, Vanderbilt-Ingram Cancer Center, Harold C. Simmons Comprehensive Cancer Center, The Ohio State University, The University of Texas Southwestern Medical Center

OpenAlex ID: A5113522751

Dendritic Cells in Antitumor Immune Responses

1996 · Dmitry I. Gabrilovich, I.Frank Ciernik, et al. · Cellular Immunology · 290

Dendritic Cells in Antitumor Immune Responses

1996 · Dmitry I. Gabrilovich, Sorena Nadaf, et al. · Cellular Immunology · 213

Immunologic Dysfunction in Cancer

1996 · Denise Yardley Kavanaugh, David P. Carbone · Hematology/Oncology Clinics of North America · 78

Structural and functional analysis of β2 microglobulin abnormalities in human lung and breast cancer

1996 · Hailei L. Chen, Dmitry Gabrilovich, et al. · International Journal of Cancer · 63

Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell lung cancer

2025 · Jacob M. Sands, Stéphane Champiat, et al. · Cancer · 52

Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer

2001 · Yasushi Adachi, Fumio Itoh, et al. · International Journal of Cancer · 45

IL-12 and Mutant P53 Peptide-Pulsed Dendritic Cells for the Specific Immunotherapy of Cancer

1996 · Dmitry I. Gabrilovich,, H Thomas Cunningham, et al. · Journal of Immunotherapy · 39

P53 as a target for anti-cancer immunotherapy

1997 · Hailei L. Chen, David P. Carbone · Molecular Medicine Today · 26

Biological Considerations in Lung Cancer

2001 · Bond Almand, David P. Carbone · Cancer treatment and research · 7

Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis

2025 · Hong Li, Chi‐Ling Chiang, et al. · Advanced Science · 4

Abstract 2861: Comparative genomics of gut commensal Lachnospiraceae and their associations with cancer treatment response with immune checkpoint inhibitors

2026 · Shiva Jahanbakhshi, Amna Bibi, et al. · Cancer Research · 1

Practical Management of Adverse Events in Patients Receiving Tarlatamab, a DLL3-targeted Bispecific T-cell Engager Immunotherapy, for Previously Treated Small Cell Lung Cancer

2024 · Jacob M. Sands, Stéphane Champiat, et al. · medRxiv · 1

Abstract 63: Intratumoral Candida albicans associates with hypoxia and poor outcomes in non small cell lung cancer (NSCLC).

2026 · Dipankor Chatterjee, Dennis J. Grencewicz, et al. · Cancer Research

Works count: 14

Citation count: 820

H-index: 8

I10-index: 8